National Comprehensive Cancer Network



About NCCN

Improving the Utility of Value Tools in Cancer Care for Patients

New NCCN Patient Education Materials Help Patients Combat Nausea and Vomiting; New Patient App Now Available

Opioid Use Drops after Active Treatment, but Most Older Patients with Breast Cancer Continue Treatment for Distress and Anxiety into Survivorship

NCCN Imaging Appropriate Use Criteria Published for 15 Additional Guidelines

Recording Now Available! NCCN Press Conference - JUST BAG IT: The NCCN Campaign for Safe Vincristine Handling

NCCN Chemotherapy Order Templates to be Integrated into Cerner’s Electronic Health Record

NCCN Challenges Medical Community to “Just Bag It” to Eradicate Deadly Medical Error

Distress Screening in Oncology Leads to Better Doctor-Patient Relationships and Improved Outcomes

Adding oxidative stress to FLT3 inhibition proves promising combination against AML (University of Colorado Cancer Center)

Dana-Farber Cancer Institute announces lung cancer research collaboration (Dana-Farber Cancer Institute)

Freeze Therapy: An Alternative to Breast Cancer Surgery? (St. Louis Post-Dispatch)

Common prostate cancer treatment linked to later dementia, researcher says (Stanford Cancer Institute)

New Report Questions Value of Mammograms (NBC News)

New study questions value of mammograms for breast cancer screening (CBS News)

How a Cancer Patient Gives Back to Her Doctor (The Wall Street Journal)

IBM Watson, Quest Diagnostics, Memorial Sloan Kettering Cancer Center, MIT, Harvard combine forces for massive oncology, precision medicine initiative (Healthcare IT News)

New NCCN Patient Resources Assist Decision-Making for People with Stomach Cancer

NCCN Congress to Explore Complex Issues in Treating Hematologic Malignancies

NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms

NCCN Imaging Appropriate Use Criteria to be Integrated into New Century Health’s Oncology Clinical Decision Support Platform

Even with Genetic Predisposition for Lung Cancer, Quitting Smoking Reduces Risk (Siteman Cancer Center at Barnes Jewish Hospital and Washington University School of Medicine)

Obesity Linked to Improved Survival in Kidney Cancer (Dana-Farber Cancer Institute)

New Drugs for Ovarian Cancer Patients (The Wall Street Journal)

There’s New Hope for Blood Cancer, and It Comes from Umbilical Cords (The Washington Post)

Stanford Chemists Develop a New Method of Cancer Immunotherapy (Stanford Cancer Institute)

Johns Hopkins Scientists Track Metabolic Pathways to Find Drug Combinations for Pancreatic Cancer (The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

Breast Cancer Cells Found to Switch Molecular Characteristics (Massachusetts General Hospital Cancer Center)

In Sub-Saharan Africa, Cancer can be an Infectious Disease (University of Colorado Cancer Center)

Researchers Find a New Way to Identify and Target Malignant Aging in Leukemia (UC San Diego Health)

Study Uncovers Molecular Switch That May Sensitive Triple-Negative Breast Cancers to Immunotherapy (University of Colorado Cancer Center)

Radiologists Detect Breast Cancer in “Blink of an Eye” (Brigham and Women’s Hospital)

Outpatient Bloodstream Infections Costly for Pediatric Stem Cell Transplant and Cancer Patients (Dana-Farber/Brigham and Women’s Cancer Center)

Retinoic Acid Suppresses Colorectal Cancer Development (Stanford Cancer Institute)

Electronic Health Record Data Can Help Determine Highest Risk of Early Death from Chemotherapy in Older Patients with Lymphoma

NCCN Awards 3 Grants to Investigators to Study Bavituximab in Combination with Other Therapeutic Strategies in Various Cancers

The Days of Biosimilars and Molecular Testing Are Here; Are We Ready?

New NCCN Imaging Appropriate Use Criteria Published for Eight Cancer Types

NCCN Imaging Appropriate Use Criteria to be Integrated into MedCurrent’s OrderWise Platform

U.S. Ranks First in Health Care Spending, but Cancer Outcomes Do Not Reflect the Investment, Study Finds

Secrets of Age-Related Diseases May Lie in Cellular Targets Identified by Roswell Park/Everon Team (Roswell Park Cancer Institute)

Vitamin D Receptor Protein May Reduce Odds of Being Diagnosed with Aggressive Breast Cancer (Roswell Park Cancer Institute)

Novel Statistical Method Captures Long-Term Health Burden of Pediatric Cancer Cures (St. Jude Children’s Research Hospital)

Novel Statistical Method Captures Long-Term Health Burden of Pediatric Cancer Cures (St. Jude Children’s Research Hospital)

Cord Blood Outperforms Matched, Unrelated Donor in Bone Marrow Transplant (University of Colorado Cancer Center)

Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain (Mayo Clinic Cancer Center)

Two Ongoing Studies Evaluate Health Effects of E-cigarettes (The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute)

Fox Chase Cancer Center Researchers Identify Mechanism for Drug Resistance in Ovarian Cancer (Fox Chase Cancer Center)

Massion Named to Lead New Cancer Prevention Initiative (Vanderbilt-Ingram Cancer Center)

Protein ZMYND8 Tied to Suppression of Prostate Cancer Tumor Metastasis (The University of Texas MD Anderson Cancer Center)

NCCN Imaging Appropriate Use Criteria to be Integrated into National Decision Support Company’s CareSelect Imaging

More Nonsmoking Teens Inhaling Flavored Nicotine through Vaping (The New York Times – Well Blog)

Acupressure May Ease Fatigue after Breast Cancer (Foxnews.com)

Deadly and Beautiful: The Mesmerizing Images of Cancer Research (The Washington Post)

Mayo Clinic Researchers Identify Potential Immunotherapy Drug Combination for Targeting Advanced and Metastatic Cancers (Mayo Clinic Cancer Center)

Roswell Park-Led Study: Photoacoustic Imaging is Promising Option for Noninvasive Monitoring of Prostate Cancer (Roswell Park Cancer Institute)

National Comprehensive Cancer Network Joins AllTrials campaign for Clinical Trial Transparency (AllTrials.net)

Go-Between Immune Cell is Key to Priming the Body’s Fight against Cancer (UCSF Helen Diller Family Comprehensive Cancer Center)

Scientists Trace Origin Cell of Bone and Soft Tissue Tumors, Test Drug Target (Duke Medicine)

I Thought Melanoma Would Kill Me. Here’s Why It Didn’t. (The Washington Post)

Helping Patients Assess the Real Value of Cancer Care (The Philadelphia Inquirer – Diagnosis: Cancer)

Older Women in the United States Not Receiving Recommended Bone Density Testing before Starting Cancer Treatment, Study Finds

NCCN Accepted as CMS-Approved Provider-Led Entity for Development of Imaging Appropriate Use Criteria

NCCN Publishes New Patient Education Resources about Myelodysplastic Syndromes

Duke Scientists Identify Method of Action for Common Chemotherapy Drugs (Duke Cancer Institute)

In Human Clinical Trial, UAB to Test Diet’s Effect on Ovarian Cancer Patients (University of Alabama at Birmingham Comprehensive Cancer Center)

Stanford Scientists Create ‘Guided Chemotherapy Missiles’ that Target Cancer Cells and Spare Health Ones (Stanford Cancer Institute)

Women’s Long Work Hours Linked to Alarming Increases in Cancer, Heart Disease (The Ohio State University)

Lack of Exercise is Associated with Ovarian Cancer Risk and Survival, But How Much Exercise is Enough? (Roswell Park Cancer Institute)

Study Finds Patient Navigators Improve Comprehensive Cancer Screening Rates (Massachusetts General Hospital Cancer Center)

Surgery Can Lengthen Survival of Metastatic Kidney Cancer Patients Treated with Targeted Therapies, Study Finds (Dana-Farber/Brigham and Women’s Cancer Center)

New Cancer Immunotherapy Drugs Linked To Arthritis in Some Patients (The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

Methotrexate Exposure Impacts Cognitive Processes Cancer Survivors Need to Multitask (St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center)

Whole-Exome Sequencing Predicts which Bladder Cancers and Common Cell Lines Respond to Cisplatin (University of Colorado Cancer Center)

Moffitt Cancer Center Study Identifies Disparities in Breast Cancer Risk Management among Those Genetically Susceptible to the Disease (Moffitt Cancer Center)

Body’s Own Gene Editing System Generates Leukemia Stem Cells (UC San Diego Moores Cancer Center)

Drinking after Diagnosis (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

New Imaging Technique Distinguishes Cell Types in Breast Tumor Environment (University of Wisconsin Carbone Cancer Center)

Are We Ready for the Moonshot?

New Education Materials from NCCN Empower Patients with Rare Lymphoma

High-Quality Management of Physical and Depressive Symptoms May Reduce Severe Anxiety at End of Life for Patients with Cancer, Study Finds

Are We Ready for the Moonshot?

Patient-Focused NCCN Guidelines for Non-Hodgkin Lymphoma Reflect Dramatic Changes in Treatment

Progression-Free Survival Triples in Select Metastatic Lung Cancer Patients with Surgery or Radiation after Standard Chemotherapy (The University of Texas MD Anderson Cancer Center)

The New Front Line in Melanoma: Immunotherapy OR Targeted Agents? (Cure)

The Birth and Evolution of NCCN (Oncology Times)

Sisters Diagnosed Weeks Apart Fight Breast Cancer Together (CBS News)

How Much Do You Want to Know About Your Cancer? (The New York Times)

Two-Drug Immunotherapy Deemed Safe for Small Cell Lung Cancer Patients, Moffitt Study Shows (Moffitt Cancer Center)

Investigational Immunotherapy Drug Shrinks Tumors in High-Risk Neuroblastoma Patients (St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center)

Biosimilar Shows Comparable Efficacy, Safety to Trastuzumab in Advanced Breast Cancer (ASCO)

Moffitt Researchers Report Improved Progression-Free Survival and Responses Rates for Lutathera over Octreotide in Patients with Progressive Metastatic Midgut Neuroendocrine Tumors (Moffitt Cancer Center)

Lenalidomide Maintenance Therapy Improves Overall Survival for Patients with Multiple Myeloma (Roswell Park Cancer Institute)

Innovative Direct-to-Patient Outreach May Accelerate Breast Cancer Research (ASCO)

Increase in Obesity among Pediatric Hodgkin Lymphoma Patients May be Linked to Disease Relapse (Roswell Park Cancer Institute)

Hispanic and Black Young Adult Cancer Patients More Likely to Die of Their Disease (University of Colorado Cancer Center)

Nivolumab Shows Promise in First-Ever Trial for Patients with Refractory, Metastatic Anal Cancer (The University of Texas MD Anderson Cancer Center)

Nivolumab Immunotherapy Helps Patients with Advanced Bladder Cancer (The University of Texas MD Anderson Cancer Center)

Ten Years of Hormone Therapy Reduces Breast Cancer Recurrence without Compromising Quality of Life (ASCO)

NCCN Awards Research Grants to Eight Investigators to Support Clinical and Pre-Clinical Studies of Mirvetuximab Soravtansine in Various Cancers

New NCCN Imaging Appropriate Use Criteria Resources Help Assure Patients Receive Best Cancer Care Available

NCCN Media Tip Sheet: Spring 2016 Edition

NCCN Receives Funding for Policy and Advocacy Fellow

New NCCN Resources for Non-Hodgkin's Lymphomas Empower Patients to Make Informed Treatment Decisions

NCCN 21st Annual Conference Convened Experts in Key Oncology Issues; New and Updated NCCN Guidelines Presented

NCCN Panel Assesses Health Care Policy Winds in an Election Year: Payment Reform, Data Sharing, and Patient Access

In the Face of Chronic Pain, Clinicians Seek Best Practices for Management while Evading Opioid Abuse

For Breast Cancer, When to Screen or Not to Screen? That is the Question Plaguing the Minds of U.S. Women—and Their Clinicians

Timothy J. Eberlein, MD, Elected Chairman of the NCCN Board of Directors; New Officers Elected

NCCN Welcomes University of Wisconsin Carbone Cancer Center to Its Alliance of Leading Cancer Centers

NCCN Expert Panel Sets the Record Straight on Palliative Care and its Value in the Cancer Care Continuum

NCCN Foundation Awards Grants to Six Young Investigators

Who Really Needs a Colonoscopy? (The Philadelphia Inquirer)

When Gene Tests for Breast Cancer Reveal Grim Data but No Guidance (The New York Times)

The Rate of Double Mastectomies Has Tripled In 10 Years: Study (TIME)

Neurofeedback Reduces Pain, Increases Quality of Life for cancer Patients Suffering from Chemotherapy-Induced Neuropathy (The University of Texas MD Anderson Cancer Center)

Rattled by Drug Price Increases, Hospitals Seek Ways to Stay on Guard (The Washington Post)

Financial Burden of Cancer Can Harm Quality of Life (Fox News Health)

Higher Volume Radiation Facilities Associated with Better Survival Rates for Men with High Risk Prostate Cancer (Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center)

Research in the News: Key Protein in Pancreatic Cancer Growth May Also be Its Undoing (Yale Cancer Center/Smilow Cancer Hospital)

Anticancer Drug Restores Hearing in Some Patients with Neurofibromatosis (The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

Anticancer Drug Restores Hearing in Some Patients with Neurofibromatosis (The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)

New Agent Overcomes Drug Resistance in HER2-Positive Breast Cancer, Preclinical Study Shows (Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center)

New Lung Cancer Therapy May Target Previously Untreatable Tumors (Memorial Sloan Kettering Cancer Center)

UCSF Research Suggests New Model for Cancer Metastasis (UCSF Helen Diller Family Comprehensive Cancer Center)

New MD Anderson-Developed Breast Cancer Staging System Emphasizes Importance of Tumor Biology as Prognostic Indicator (The University of Texas MD Anderson Cancer Center)

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patients (Huntsman Cancer Institute at the University of Utah)

How Much Does Chemo Impact Fertility? (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

How Much Does Chemo Impact Fertility? (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

Cancer Center Awards First ‘Impact Grants’ for High-Risk, High-Reward Projects (UCSF Helen Diller Family Comprehensive Cancer Center)

Stealth Mode: How Metastatic Cancer Cells Evade Detection by the Immune System (Memorial Sloan Kettering Cancer Center)

Beating Prostate Cancer: “We’re Taking off the Brakes” (City of Hope Comprehensive Cancer Center)

Interventions Required to Reduce Non-Cancer-Related Hospitalizations for Elderly Men after Prostate Cancer Diagnosis, Study Finds

Cancer Care in an Election Year, Palliative Care Challenges, Incorporating Patient Values, and Guidelines Updates Featured at NCCN Annual Conference

Moffitt Cancer Center Researchers Target Specific Protein Associated with Poor Survival and Treatment Resistance in Brain Cancer Patients

Quantifying Aspirin’s Reduction in Cancer Risk (The New York Times)

More Women with Cancer in One Breast are Having Double Mastectomies. That Might Not be a Good Idea. (The Washington Post)

When Prostate Cancer Spreads, Where it Goes Matters—a Lot (STAT)

Diabetes Treatment May Affect Breast Density (U.S. News & World Report)

Study Identifies Possible Marker for Lung Cancer Chemotherapy (The Ohio State University Comprehensive Cancer Center –James Cancer Center and Solove Research Institute)

In Defense of the Negative Result (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

Unpacking Space Radiation Key to Controlling Astronaut and Potentially Earthbound Cancer Risk (University of Colorado Cancer Center)

Certain Biopsy Method Tied to Better Outcomes after Kidney Cancer (U.S. News & World Report)

Living with Cancer Blog: Check These Resources for Online Cancer Treatment Guidelines (Mayo Clinic Cancer Center)

Breast Cancer Triggers PTSD Symptoms in 80% of Women (Medscape)

Subject Matter Experts - NCCN 21st Annual Conference

New Algorithm Adopted by NCCN for Reducing Cardiovascular Disease in Prostate Cancer (Cancer Therapy Advisor)

New Wrinkle in NCCN's Iconic Guides: Cost (Medscape)

New Lymphoma and Leukemia Patient-Friendly Guides Put Out by the NCCN, a Cancer Network

MEDIA ADVISORY: Cancer Care in an Election Year and Incorporating Patient Values Among Highlights at NCCN Annual Conference, March 31–April 2, 2016

Test Media

Test Media

Test Media

Is Metastatic Prostate Cancer Tailor-Made for Precision Oncology? (Fred Hutchinson Cancer Research Center)

New Genetic Insights into Mesothelioma (Brigham and Women’s Hospital)

For Cancer Patients, Pain May Rise as Finances Dwindle (The Philadelphia Inquirer)

Cancer Cells Turn Body’s Immune System to "Dark Side" in Most Common Form of Lung Cancer (University of Colorado Cancer Center)

Waste in Cancer Drugs Costs $3 Billion a Year, a Study Says (The New York Times)

New IOM Report Underscores Diversity of Ovarian Cancer Subtypes, Highlights Research Priorities (Roswell Park Cancer Institute)

Dietary Glycemic Index Linked to Lung Cancer Risk in Select Populations (The University of Texas MD Anderson Cancer Center)

Women Often Overestimate Odds That Early Breast Cancer Will Return, Spread (U.S. News and World Report)

Media Category Test

Advisories Category Test

NCCN Publishes New Patient Education Resources for Patients with Chronic Lymphocytic Leukemia and Hodgkin Lymphoma—a Rare, Yet Curable, Cancer

NCCN Publishes New Patient Education Resources for Patients with Chronic Lymphocytic Leukemia and Hodgkin Lymphoma—a Rare, Yet Curable, Cancer

Roswell Park Teams Awarded Nearly $7 Million in Research Funding (Roswell Park Cancer Institute)

New Image Analytics May Offer Quick Guidance for Breast Cancer Treatment (Case Western Reserve University)

Crafting a Better T Cell for Immunotherapy (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

Are Lung Cancer Survivors Getting Too Many Costly Scans for No Reason? Study Suggests So (University of Michigan Comprehensive Cancer Center)

BRCA Clinics Expand Further Beyond Breast Cancer (The Wall Street Journal)

Juno Therapeutics, Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center Announce New Immuno-Oncology Clinical Trials Unit (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

Laurie H. Glimcher, MD, Named President of Dana-Farber Cancer Institute (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)

CAR Trials Drive Leukemia and Lymphoma Treatment in New Direction (UC San Diego Moores Cancer center)

New Research Shows How Financial Engineering Could Make Life-Saving Drugs More Available and Affordable (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)

Frozen Section Analysis for Breast Cancer Could Save Time, Anxiety and More Than $90 Million (Mayo Clinic Cancer Center)

Childhood Leukemia Patients from High-Poverty Areas More Likely to Suffer Early Relapse (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)

Moffitt Researchers Develop a Novel Cancer Treatment Approach Based on Evolutionary Principals to Inhibit Chemo-Resistance, Prolong Progression-Free Survival (Moffitt Cancer Center)

International Collection of Open Reading Frames Now Totals 80 Percent of Human Protein-Coding Genes, Collaboration Reports (Dana-Farber/Brigham and Women’s Cancer Center/Massachusetts General Hospital Cancer Center)

All Pain and No Gain: Increased Treatments, Cost and Side Effects Do Little in Increase Survival in Elderly Advanced Stage Colorectal Cancer Patients (University of Colorado Cancer Center)

Chemo Better Option Following Pancreatic Cancer Surgery: Study (Vanderbilt-Ingram Cancer Center)

Study Finds Mechanism by which Obesity Promotes Pancreatic and Breast Cancer (Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center)

Discovery Lays the Foundation to Expand Personalized Chemotherapy for Leukemia Patients (St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center)

Some Chemotherapy Drugs May Increase the Percentage of Patients whose Tumors Respond to Immune Checkpoint Therapy (Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center)

MD Anderson Researchers Propose New Staging for HPV-Related Oropharyngeal Cancer (The University of Texas MD Anderson Cancer Center)

Immune-Targeting Drug Combo Shows Promise for Non-Small Cell Lung Cancer Patients, Say Moffitt Cancer Center Researchers (Moffitt Cancer Center)

New Predictor of Cancer (Robert H. Lurie Comprehensive Cancer Center of Northwestern University)

Chemotherapy before Chemoradiation Shows No Survival Advantage in Head and Neck Cancer (University of Colorado Cancer Center)

Chemoradiation May Increase Survival for a Subset of Elderly Head and Neck Cancer Patients (University of Colorado Cancer Center)

NCCN, in Collaboration with Pfizer, Awards 10 Grants for Provider Performance and Quality in Treatment of Metastatic Breast Cancer Initiatives

New NCCN Guidelines Include Evidence Blocks to Illustrate Value in Breast, Colon, Kidney, and Rectal Cancers

NCCN Awarded $2 Million in Research Funding from Infinity Pharmaceuticals to Study Duvelisib in Hematologic Malignancies

Proton Therapy Controls Common Pediatric Brain Tumor with Fewer Long-Term Side Effects (Massachusetts General Hospital Cancer Center)

Does Radiation Therapy Improve Survival for Women with Ductal Carcinoma in Situ (DCIS)? Yes...and...No. (Dana-Farber/Brigham and Women’s Cancer Center)

Shedding New Light on Breast Cancer Metastases (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

Investigating Surgery for Women at High Risk of Breast and Ovarian Cancer (Mayo Clinic Cancer Center)

Renowned Oncologist Dr. Marc Ernstoff to Assume Leadership Roles at UB, Roswell Park (Roswell Park Cancer Institute)

Prostate Cancer Survivors’ Risk of Heart Disease Studied (Vanderbilt-Ingram Cancer Center)

Meditation Eases Pain, Anxiety and Fatigue during Breast Cancer Biopsy (Duke Cancer Institute)

NCCN Supports the Global Fight against Cancer on World Cancer Day 2016

Targeted Axillary Dissection of Lymph Nodes after Chemotherapy Improves Staging Accuracy of Node-Positive Breast Cancer Patients

Smokers Who Quit More Than 15 Years Ago Need Screening

Smoking Lowers Breast Cancer Survival, Study Finds

Survival Period for Esophageal Cancer Is Tied to Race and Income

Nivolumab Combined with Radiation Therapy May Be New Treatment Option for Patients with Melanoma Brain Metastases, Say Moffitt Cancer Center Researchers

Cancer Centers Urge Increase in HPV Vaccinations

Groundbreaking Collaborative Breast Cancer Study Aims to Unlock the Doors of Individualized Patient Care with Big Data

Groundbreaking Collaborative Breast Cancer Study Aims to Unlock the Doors of Individualized Patient Care with Big Data

Groundbreaking Collaborative Breast Cancer Study Aims to Unlock the Doors of Individualized Patient Care with Big Data

Groundbreaking Collaborative Breast Cancer Study Aims to Unlock the Doors of Individualized Patient Care with Big Data

NCCN Publishes New Clinical Practice Guidelines for Vulvar Cancer

A Statement from NCCN in Support of a Moonshot to Cure Cancer

NCCN Supports President Obama and Vice President Biden in their Moonshot to Cure Cancer Initiative

NCCN Awards Research Grants to Five Investigators to Study Effectiveness of Enzalutamide in Various Cancers

NCCN Awards Grants to Three Researchers to Investigate Volasertib in Hematologic Malignancies

NCCN Awarded $2 Million in Research Funding from Peregrine Pharmaceuticals to Study Bavituximab in Various Cancers

Genetic Mutations Differ within a Single Tumor, Study Finds; University of Michigan Comprehensive Cancer Center

Depressed Head and Neck Cancer Patients Three-and-One-Half Times Less Likely to Survive, Have Higher Recurrence Risk, The University of Texas MD Anderson Cancer Center

Study Shows Abiraterone Acetate is Useful Even in Most Aggressive Prostate Cancers; University of Colorado Cancer Center

‘Purity’ Of Tumor Samples May Significantly Bias Genomic Analyses, UCSF Helen Diller Family Comprehensive Cancer Center

Experimental Drug is First Targeted Therapy to Improve Survival in Certain High-Risk AML Patients, Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

NCCN Collaborates with Bristol-Myers Squibb to Study PD-L1 Expression and Test Interpretation in Lung Cancer

New Class of RNA Tumor Suppressors Identified (Stanford Cancer Institute)

Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors (UC San Diego Moores Cancer Center)

Scientists Identify Strategy to Prevent Renal Failure, Also Hit on Opportunities to Improve Cancer Treatment (Roswell Park Cancer Institute)

Tumor-suppressor p53 Regulates Protein that Stifles Immune Attack on Cancer (The University of Texas MD Anderson Cancer Center)

Study Provides New Clues about the Diversity of Prostate Cancer Subtypes (Memorial Sloan Kettering Cancer Center)

Personalized Drug Screening on the Horizon for Multiple Myeloma Patients (Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine)

Without Prescription Coverage, Some Cancer Patients Do without Even Low-Cost, High-Benefit Drugs (University of Colorado Cancer Center)

Study Could Result in New Strategies For Treating Juvenile Cancer (St. Jude Children's Research Hospital/University of Tennessee Health Science Center)

Possible New Mechanism for Aspirin's Role in Cancer Prevention (Huntsman Cancer Institute at the University of Utah)

NCCN Foundation® Appoints Three New Representatives to Board of Directors

Dr. Robert C. Young Joins NCCN Leadership Team

View the NCCN Press Conference - NCCN Guidelines with NCCN Evidence Blocks: A View of the Patient-Empowered Cancer Conversation

NCCN Unveils Evidence Blocks for CML and Multiple Myeloma

MEDIA ADVISORY: NCCN to Unveil Oncology Value Tool at Oct. 16 Press Conference in San Francisco

NCCN Publishes New Patient Education Resources for Kidney Cancer

NCCN Publishes New Patient Education Resources for Kidney Cancer

NCCN Publishes New Patient Education Resources for Kidney Cancer

NCCN Publishes New Patient Education Resources for Kidney Cancer

NCCN Publishes a Resource-Stratified Framework of Clinical Practice Guidelines for Cervical Cancer

NCCN Seeking Poster Presentations from Nation’s Top Oncology Researchers

Molecule in Donor Cells May Be Key to Better Outcomes for Transplant Patients

Will One Bad Sunburn Give You Skin Cancer?

Yale Study Identifies ‘Major Player’ in Skin Cancer Genes

Fertility after Cancer: Young Woman Less Likely to be Told about Options

Gene Therapy May Improve Survival of Patients with Recurrent Ovarian Cancer

New Drug for Blood Cancers Now in Five Phase II Clinical Trials

'Jaw-Dropping': Medicare Deaths, Hospitalizations AND Costs Reduced

Targeted Therapy Shows Effectiveness against a Subtype of the Brain Tumor Medulloblastoma

Scientists at City of Hope and UCLA Stop Tumor Growth with Nanoparticles

Simple Mouth Rinse Could Help Predict Recurrence of HPV-Related Oropharyngeal Cancers

Exercise during Adolescence Linked to Lowered Risk of Death Later

Moffitt Cancer Center Researchers Develop First Genetic Test to Predict Tumor Sensitivity to Radiation Therapy

Poor Survival in Multiple Myeloma Patients Linked to Genetic Variation

Lymph Node Radiation May Halt Breast Cancer Recurrences

Lymph Node Radiation May Halt Breast Cancer Recurrences

For Prostate Cancer Patients, Risk-Specific Therapies Now More the Norm

Study Explores Protein’s Role in Inflammation-Associated Cancer

Researchers Decode Molecular Action of Combination Therapy for a Deadly Thyroid Cancer

Doctors Speak Out Against 'Unsustainable' Rise In Cancer Drug Prices

Similarities between Embryos and Breast Tumors Identified (The University of Texas MD Anderson Cancer Center)

Mayo Clinic Study Suggests which Glioblastoma Patients May Benefit from Drug Treatment (Mayo Clinic Cancer Center)

10 Years to Cancer Cures 'Actually Plausible,' Fred Hutch President Says (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)

Protein’s Impact on Colorectal Cancer is Dappled (UC San Diego Moores Cancer Center)

Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria (Roswell Park Cancer Institute)

Salmonella Bacterium Could Prove Potent Foe to Aggressive Form of Pancreatic Cancer (City of Hope Comprehensive Cancer Center)

Finding Better Ways to Fight Cancer Means Starting with the Basics (Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center)

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Targeted Combination Approaches with Afatinib in Lung Cancer

NCCN Collaborates with Pfizer to Improve Provider Performance and Quality in Treatment of Metastatic Breast Cancer

Oncology Experts to Deliberate Tissue Allocation Issues at Upcoming NCCN Policy Summit

Oncology Experts to Deliberate Tissue Allocation Issues at Upcoming NCCN Policy Summit

Flatiron Health to Incorporate NCCN Chemotherapy Order Templates into OncoEMR®

NCCN Receives $2-Million Funding Commitment from ImmunoGen, Inc. to Study Mirvetuximab Soravtansine for Folate Receptor Alpha-Positive Cancers

NCCN Foundation Awards Grants to Six Young Investigators

Final Roundtable of the NCCN 20th Annual Conference Explores Essential Characteristics of Clinical Practice Recommendations

NCCN Holds Fourth Annual State Oncology Society Forum

Highlights from the NCCN 20th Annual Conference Include Expert Roundtables, Presentation of New and Updated Treatment Guidelines

NCCN and ECO Collaborate to Translate and Regionally Adapt NCCN Guidelines

Disparities in Defined Value Pose Challenges to Oncology Decision-Makers, Say NCCN Panelists

New NCCN Member Institution: Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute

20 Years of Improving Cancer Care Together – An NCCN Roundtable Discussion

NCCN Publishes New Guidelines for Smoking Cessation

Preliminary NCCN Guidelines® for Global Resource Stratification™: Cervical Cancer Now Available

Clinical Trials, Advanced Genetic Profiling, Improved Patient Categorization Have Led to Improved Outcomes in Acute Myeloid Leukemia since 1996

Chemotherapy and Improved Surgical Techniques Noted as Important Advancements in Treating Ovarian Cancer over the Last Two Decades

NCCN 20th Annual Conference Will Highlight 20 Years of Cancer Treatment Improvements and Explore Value in Oncology; New and Updated NCCN Guidelines®

NCCN Publishes New Patient-Friendly Treatment Guidelines for Acute Lymphoblastic Leukemia

CMS Oncology Care Model Names NCCN Guidelines as High-Quality Care and Evidence-Based Recommendations

Looking Back on Two Decades of Breast Cancer Treatment: Targeted Therapy and Improved Surgical Procedures are Key Enhancements

NCCN Celebrates 20 Years of Improving Cancer Care

NCCN Celebrates 20 Years of Improving Cancer Care

Access to High-Quality Cancer Care Eliminates Racial Disparities in Survival, Study Finds

NCCN and Flatiron Health Announce Collaboration to Launch Novel Oncology Outcomes Database

Immunotherapy, Genomic Profiling and Potential Game Changing Drugs Lead List of 2014 Dana-Farber Research Highlights

Cancer-Causing Mutation Discovered in 1982 Finally Target of Clinical Trials

1.5 Million Lives Spared by Cancer Death Rate Reduction in 20 Years, Study Says

Bad Luck of Random Mutations Plays Predominant Role in Cancer, Study Shows

NCCN Publishes New Patient-Friendly Treatment Guidelines for Acute Lymphoblastic Leukemia

NCCN Launches 3D Virtual Simulator Learning Platform

“U.S. Smoking Rate Dips Again,” The New York Times

“Research on a Rare Cancer Exposes Possible Route to New Treatments,” Huntsman Cancer Institute at the University of Utah

“Protein Predicts Response to New Immunotherapy Drug,” Yale Cancer Center/Smilow Cancer Hospital

“Protein Predicts Response to New Immunotherapy Drug,” Yale Cancer Center/Smilow Cancer Hospital

“Breast Cancer Vaccine Shows Promise in Slowing Progress,” TIME.com

“Your Odds of Surviving Cancer Depend Very Much on where You Live,” NPR.com

Changing the Course of Prostate Cancer Treatment: Life Expectancy Estimation, Active Surveillance, and Drug Development

“Potential Therapy Found for Incurable Pediatric Brain Tumor,” Robert H. Lurie Comprehensive Cancer Center at Northwestern University

“Study Reveals How Some Breast Cancers Become Resistant to Targeted Drugs,” Memorial Sloan Kettering Cancer Center

“Moffitt Cancer Center Researchers Use Evolutionary Principles to Model Cancer Mutations, Discover Potential Therapeutic Targets,” Moffitt Cancer Center

“Power behind ‘Master’ Gene for Cancer Discovered,” The University of Texas MD Anderson Cancer Center

“Study Shows Link Between Genes, Seaside Vacations & Future Melanoma Risk,” University of Colorado Cancer Center

Improved Outcomes in Non-Small Cell Lung Cancer Due to Advancements in Screening, Diagnosis, Radiology, and Systemic Therapies

"New Test Developed at Dana-Farber/Brigham and Women's Cancer Center Speeds Treatment Decisions for Blood Cancer Patients," Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

"MD Anderson’s David M. Gershenson, MD, Receives IGCS’s Award for Excellence in Gynecologic Oncology," The University of Texas MD Anderson Cancer Center

"Cancer-Killing Virus Plus Chemotherapy Drug Might Treat Recurrent Ovarian Cancer," The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

"Gene Sequencing Projects Link Two Mutations to Ewing Sarcoma Subtype with Poor Prognosis," St. Jude Children’s Research Center/The University of Tennessee Health Science Center

"Colorectal Cancer Rates Increasing for U.S. Adults Under 50," Oncology Nurse Advisor

"Promising Prognostic Biomarker Candidates for Ovarian Cancer Uncovered by Roswell Park Team," Roswell Park Cancer Institute

"Dr. Candace Johnson Named Cancer Center Director at Roswell Park Cancer Institute," Roswell Park Cancer Institute

"Researchers Take New Approach to Stop 'Most Wanted' Cancer Protein," Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

"Mayo Clinic Researchers Identify First Steps in Formation of Pancreatic Cancer," Mayo Clinic Cancer Center

"Yale Study: Medicare Costs for Breast Cancer Screenings Soar, but Benefits Remain Unclear," New Hampshire Register

"As U.S. Cases of Skin Cancer Rise, Costs Skyrocket, Too," Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Printed NCCN Guidelines for Patients® Now Available through Amazon.com

NCCN Chemotherapy Order Templates to be Integrated into Epic’s Electronic Health Record

Looking Back: 20 Years of Colorectal Cancer Treatment Breakthroughs Improve Survival, Advance Evidence-Based Choices

Looking Back: 20 Years of Colorectal Cancer Treatment Breakthroughs Improve Survival, Advance Evidence-Based Choices

Oncology Experts and Patient Advocates to Deliberate Patient Concerns: Big Data, Access to Quality Cancer Care, and Palliative Care

Cigna Using NCCN Content for Oncology Coverage Policy Development

Four Researchers Awarded Grants to Investigate Effectiveness of Nintedanib* in Lung, Colorectal, and Gastrointestinal Cancers

Patient-Friendly Guide Offers Free Step-by-Step Information for People with Soft Tissue Sarcoma

Poster Presentation Opportunity Available for Nation’s Top Researchers in Oncology

Oncology Experts Mark 20 Years of Evidence-Based Decision-Making in Small Cell Lung Cancer

NCCN to Host 9th Annual Congress: Hematologic Malignancies™ in New York, NY

NCCN Offers Free Webinars for Patients with Non-Small Cell Lung Cancer

Top-Ranked Hospitals for Cancer – U.S. News and World Report

“Roswell Park Cancer Institute Genomic Sequencing Test Wins New York State Approval,” Roswell Park Cancer Institute

“Huntsman Cancer Institute Receives Funding to Establish a National Clinical Trials Network Site,” Huntsman Cancer Institute at the University of Utah

“Prostate Cancer in Young Men – More Frequent and More Aggressive?” University of Michigan Comprehensive Cancer Center

“Game Theory” Model Reveals Vulnerable Moments for Metastatic Cancer Cells' Energy Production,” The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

“4 Lessons for Effective, Efficient Research in Health Care Settings,” University of Colorado Cancer Center

“Some Aggressive Cancers May Respond to Anti-inflammatory Drugs,” Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

“Study Points to Higher Risk of Breast Cancer Progression in Obese Women,” The University of Texas MD Anderson Cancer Center

“Aspirin Cuts Pancreatic Cancer Risk by Half, Study Finds,” Bloomberg

“St. Jude Children's Research Hospital Names New CEO in Memphis,” Bloomberg Businessweek

“Mayo Clinic Researchers Say Gene in Brain Linked to Kidney Cancer,” Mayo Clinic Cancer Center

“Study Sheds Light on Racial Disparity in Colon Cancer,” University of Michigan Comprehensive Cancer Center

"BPA Stimulates Growth of Breast Cancer Cells, Diminishes Effect of Treatment," Duke Cancer Institute

"Radiation for Prostate Cancer Linked to Secondary Cancers, Study Finds," University of Michigan Comprehensive Cancer Center

"Study Affirms Value of Epigenetic Test for Markers of Prostate Cancer," The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

"Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating," Moffitt Cancer Center

"Intensity Modulated Proton Therapy Shows Benefit for Head and Neck Cancer," The University of Texas MD Anderson Cancer Center

NCCN to Host Policy Summit Addressing the Impact of Health Care Reform on Academic Oncology Practice

NCCN Offers Free Patient Assistance Resource App

Six Organizations Receive Grants from NCCN and Pfizer for Health Care Quality Improvement Programs in Rare Cancers

NCCN Foundation® Awards Grants to Five Young Investigators

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Volasertib* in Hematologic Malignancies

“Pancreatic Cancer Set to Become Second Most Fatal Cancer,” TIME

“Poorer Health of Surgery Patients on Medicaid May Alter Law’s Bottom Line,” The New York Times

“Massive Dose of Measles Vaccine Clears Woman's Cancer,” USAToday.com

“A Study on Prostate Cancer Relapses Suggests that Hormone Therapy Can Wait,” The New York Times

“Lung Cancer Expert Not Buying ASCO Report on Screenings’ Cost,“ City of Hope Comprehensive Cancer Network

“Obesity May Impact Breast Cancer Survival in Younger Women,” CBSNews.com

NCCN Publishes Comprehensive Stage-Specific Breast Cancer Resources for Patients

“Tumor Suppressor Gene TP53 Mutated in 90 Percent of Most Common Childhood Bone Tumor,” St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center

“Jamming a Protein Signal Forces Cancer Cells to Devour Themselves,” The University of Texas MD Anderson Cancer Center

“Cancer and the Goldilocks Effect,” UC San Diego Moores Cancer Center

“Lack of Insurance Coverage a Barrier to Lung Cancer Screening,” Roswell Park Cancer Institute

“Likely Culprit in Spread of Colon Cancer Identified,” Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

NCCN Holds Third Annual State Oncology Society Forum

NCCN Receives $2.2 Million in Research Funding from Astellas and Medivation to Study Enzalutamide in Solid Tumors

NCCN to Host Policy Summit Concerning Biomarkers and Targeted Therapies in Clinical Trial Design

NCCN Receives $2 Million in Research Funding from Boehringer Ingelheim to Study Nintedanib* in Colorectal and Lung Cancers

Highlights from NCCN 19th Annual Conference Include Expert Roundtables, Presentation of Updated Treatment Guidelines

NCCN 19th Annual Conference Opening Roundtable: Communication is Key for Children of Parents with Cancer

Mayo Clinic Cancer Center and Yale Cancer Center/Smilow Cancer Hospital Named Newest NCCN Member Institutions

NCCN 19th Annual Conference Will Feature Expert Roundtables Exploring ACA and Children’s Experience with a Parent’s Cancer; NCCN Guidelines® Updates

NCCN and the Affordable Care Act

"Johns Hopkins Experts Identify Major Sources of High Cancer Costs," News-medical.net

"New Test Suggests Antidepressant Paxil May Promote Breast Cancer," Los Angeles Times

“Cancer Immunotherapy Treatment Shows More Promise,” The Wall Street Journal

"Addition of Bevacizumab to the Treatment of Newly Diagnosed Glioblastoma Brain Tumors Does Not Extend Patients’ Lives," Healthcanal.com

“Dismantling Pancreas Cancer’s Armor,” Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

"Peter B. Bach Discusses New Payment Reform Models Challenging Fee for Service," OBR Oncology Online

“Gene Exam Might Predict Breast Cancer Progression”, Philly.com

“Double Mastectomy May Benefit Some Women with Inherited Breast Cancer“, Fox Chase Cancer Center

“Study: Beauty Not Disease Motivates Teens to Wear Sunscreen”, University of Colorado Cancer Center

“Women, Doctors Try to Make Sense of Study on Mammograms”, The New York Daily News

NCCN Affiliate Research Consortium Offers Community Cancer Centers Cutting-Edge Research Opportunities

Margaret A. Tempero, MD, Named Editor-in-Chief of JNCCN

NCCN Appoints Gary Weyhmuller as Chief Operating Officer

NCCN Receives Esteemed Accreditation for CME Activities

“Harvard Study Shows that Nuts May Reduce Risk of Death”, The Boston Globe

“Oral Drug May Improve Survival in Men with Metastatic Prostate Cancer”, Duke Cancer Institute

“How Doctors Die: Showing Others the Way”, The New York Times

“Anal Cancer Study Offers Hope of Treatment”, San Francisco Chronicle

“Treatment, Survival for Colon Cancer Differs by Race”, Reuters.com

“Broccoli Not Burgers: Cancer Patients Favor Healthier Foods”, Reuters.com

“Adult Survivors of Childhood Cancer at Risk of Becoming Frail at an Early Age”, St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center

“Breast MRI Use Up Despite Lack of Indications”, MedPage Today

“Secret to Surviving Cancer? It might be Marriage”, USA Today

“Most Men with Breast Cancer Undergo Mastectomy, Study Finds”, U.S. News and World Report

“Long-Term Colorectal Cancer Incidence and Mortality after Lower Endoscopy”, The ASCO Post

NCCN Publishes New Patient Resource for Stage 0 Breast Cancer

NCCN Qualifies Northside Hospital Cancer Institute for Affiliate Research Project

Researchers Receive Grants from NCCN Oncology Research Program Funded through Onyx Pharmaceuticals

Onyx Press Release

Statement from Prostate Guideline Panel

NCCN Collaborates with Pfizer on Program Focused on Health Care Quality Improvement and Education

NCCN, McKesson Specialty Health, and The US Oncology Network Announce Plans for Integration with Elekta and Varian

“Study: Redefining the Criteria for ALK-Positive Lung Cancer”, University of Colorado Cancer Center

“Versatile MicroRNAs Choke off Cancer Blood Supply, Suppress Metastasis”, The University of Texas MD Anderson Cancer Center

“Brachytherapy to Treat Cervical Cancer Declines in US, Treatment Associated with Higher Survival”, Dana-Farber/Brigham and Women’s Cancer Center| Massachusetts General Hospital Cancer Center

“Mayo Clinic Oncologist and MD Anderson Researcher Named 2013 Susan G. Komen Brinker Awardees for Scientific Distinction”, Susan G. Komen

“Dental Cavities May Protect against Oral, Throat Cancers”, CBSNews.com

“VU Study Identifies DNA Changes in Drug-Resistant Cancer Cells”, Vanderbilt University

“Major Cancer Genotyping Study Logs 5,000th Tumor Profile”, Dana-Farber/Brigham and Women’s Cancer Center| Massachusetts General Hospital Cancer Center

“Breast Cancer: Online Tools Can Improve Patient Outlook”, City of Hope Comprehensive Cancer Center

“Why Painting Tumors Could Make Brain Surgeons Better”, NPR

“Platanias to Receive 2013 Milstein Award”, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

“Molecular Marker Predicts Patients Most Likely to Benefit Longest from Two Popular Cancer Drugs”, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

“Proteins in Histone Group might Influence Cancer Development, Study Shows”, The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute

“Mutations in a Gene that Impacts Immune Function Increase Susceptibility to Prostate Cancer”, Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Couple Pledges $10 Million Gift to Head and Neck Cancer Research, Treatment, The University of Texas MD Anderson Cancer Center

Perception of Fertility Affects Quality of Life in Young, Female Cancer Survivors, University of Colorado Cancer Center

Scientists Develop ‘Molecular Flashlight’ that Illuminates Brain Tumors in Mice, Stanford Cancer Institute

Enhanced Treatment, Surveillance Needed for Certain Melanoma Patients to Prevent Secondary Cancers, Moffitt Cancer Center Researchers Say, Moffitt Cancer Center

NCCN Qualifies Lehigh Valley Health Network for Affiliate Research Project

NCCN Launches International Educational Recognition Program

NCCN Launches International Educational Recognition Program

New NCCN Guidelines for Patients® Now Available for Esophageal Cancer

NCCN Roundtable Considers the Effect of Health Care Reform on Oncology Practice: Confronting Risk

NCCN Foundation® Announces 2013 Young Investigator Awards

Samuel M. Silver, MD, PhD, Elected Chairman of NCCN Board of Directors

Highlights of the NCCN 18th Annual Conference Include Expert Roundtables; Presentation of New NCCN Guidelines® for Survivorship

NCCN Holds Second Annual State Oncology Society Forum

NCCN Roundtable Considers the Changing Oncology Landscape: Evolution or Revolution?

NCCN Adds Two New Member Institutions

NCCN Opens 18th Annual Conference with Roundtable Discussion of the Cost of Cancer Care and Implications of Uncertainty

NCCN Presents New Guidelines for Survivorship

NCCN to Hold 18th Annual Conference: Pulitzer Prize-Winning Journalist Joins Expert Panel to Discuss Rising Cost of Cancer Care; New Guidelines Presented

John Greene, Senior Director of Customer Centric Engineering at Salesforce.com, Named to NCCN Foundation® Board

New NCCN Guidelines for Patients® Available for Adolescents and Young Adults with Cancer

NCCN Qualifies Community Site for Affiliate Research Project

NCCN Biomarkers Compendium Now Available

The National Comprehensive Cancer Network, The US Oncology Network and McKesson Specialty Health collaborate to offer new Value Pathways for cancer care

Researchers Receive Grants from NCCN Oncology Research Program Funded through AVEO/Astellas Collaboration

NCCN Appoints Dr. Robert Carlson as CEO

NCCN and McKesson Specialty Health Collaborate to Provide Oncology Quality Support System

Researchers Receive Grants from NCCN Oncology Research Program Funded Through GlaxoSmithKline

Researchers Receive Grants from NCCN Oncology Research Program Funded through Boehringer Ingelheim

New Pancreatic Cancer Guidelines for Patients Available from NCCN

Josh Bilenker, MD, Former Medical Officer for FDA and Partner at Aisling Capital, Named to NCCN Foundation Board

New Lung Cancer Screening Guidelines for Patients Available from NCCN

NCCN Qualifies First Community Sites for Affiliate Research Project

NCCN Foundation Announces 2012 Young Investigator Awards

Ellen Tauscher, Former Under Secretary of State for Arms Control and International Security and Member of Congress, Named to NCCN Foundation Board

Highlights of the NCCN 17th Annual Conference Include Presentations on Lung Cancer Screening, Melanoma, and Non-Hodgkin`s Lymphomas

NCCN Roundtable Considers Challenges in Optimal Care for Patients: Who Decides?

NCCN Presents New Guidelines for Acute Lymphoblastic Leukemia

NCCN Opens 17th Annual Conference with Roundtable Discussion on Cancer Care and Corporate America

NCCN to Hold 17th Annual Conference: Sam Donaldson and Clifford Goodman Lead Roundtable Discussions on Critical Issues in Cancer Care

NCCN Announces New Guidelines for Adolescent and Young Adult (AYA) Oncology

NCCN Collaborates with AVEO and Astellas on Innovative Cancer Research

New Release of NCCN Guidelines for Patients: Colon Cancer; Updated NCCN Guidelines for Patients: Prostate Cancer

NCCN Receives $2 Million in Oncology Research Funding from Boehringer Ingelheim to Investigate Afatinib in Solid Tumors

NCCN Announces New Addition to Library of Guidelines: NCCN Guidelines for Lung Cancer Screening

Jai Pausch Speaks to the Value of In-Person Visits to a Loved One with Cancer in Latest NCCN.com Column

McKesson Partners with National Comprehensive Cancer Network to Automate Access to NCCN Compendium

Videos of NCCN Breast Cancer Experts and Resources to Guide Treatment Offered on NCCN.com

NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline

Kimary Kulig, PhD, MPH Joins NCCN Staff as Vice President, Clinical & Translational Outcomes Research

NCCN/MEK Inhibitor GSK1120212 - Research Grant Opportunity

NCCN/BRAF Inhibitor GSK2118436 - Research Grant Opportunity

NCCN Experts and Asian Oncologists Collaborate to Develop Resources to Improve Care for Patients with Cancer in China

NCCN Guidelines Emphasize Patient Preference as Key to Selection of Maintenance Therapy in Follicular Lymphoma

NCCN Expert Discusses Extending Life-Saving Pediatric Treatments to Adults with Acute Lymphoblastic Leukemia

Advances in CLL Therapy Offer Prolonged Survival; Toxicities Continue to Plague Elderly Patients

Researchers Receive Grants from NCCN Oncology Research Program Funded Through GlaxoSmithKline

NCCN Awarded Accreditation by the ACPE to Provide Continuing Education Credits to Pharmacists

NCCN Receives $2M Educational Grant from Pfizer to Support Tailored Quality Improvement Plans at Leading Cancer Centers

New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options

NCCN and Experts from China Collaborate to Develop Colon, Kidney, Non-Small Cell Lung, and Ovarian Cancer Guidelines, China Editions

NCCN Breast Cancer Panel Reaffirms Current Position and Recommendation Regarding the Use of Bevacizumab in Metastatic Breast Cancer

New Malignant Pleural Mesothelioma Guidelines for Patients Available from NCCN

Researchers Receive Grants from NCCN Oncology Research Program Funded Through Pfizer

NCCN Launches NCCNChina.org, a Valuable On-line Resource for the Chinese Oncology Community

New Chronic Myelogenous Leukemia Guidelines for Patients Available from NCCN

Andrew von Eschenbach Named to NCCN Foundation Board

More Than 600 NCCN Chemotherapy Order Templates Now Available from NCCN to Enhance Patient Safety

NCCN Advances Oncology Imaging Research through the NCCN Specialized Imaging Research Consortium

Jai Pausch Addresses the Fear and Anxiety Caregivers Experience in the Aftermath of Cancer Treatment for Their Loved Ones with Cancer

NCCN Foundation Announces Young Investigator Awards

NCCN 4th Annual Asia Scientific Congress Held in Shanghai, China

NCCN Roundtable Addresses the Many Faces and Challenges of Caregivers

Jai Pausch Advises Caregivers to Balance Urgency for Care with Thoughtful Treatment Decisions in NCCN.com column

NCCN Panel Calls for Higher Standards, Better Ways of Translating Molecular Genetics into Clinical Practice

New Treatment Options Lead to Steady Progress Against Ovarian Cancer; Clinical Trials Remain Imperative

Active Surveillance Monitoring More Stringent in Updated NCCN Guidelines for Prostate Cancer

Post-Transplant Lymphoproliferative Disorder Section Integrated into Updated NCCN Guidelines for NHL

Second-Line TKIs Offer Expanded Treatment Options for Newly Diagnosed Patients with CML

New Therapies for Metastatic Disease Addressed in Updated NCCN Guidelines for Breast Cancer

National Comprehensive Cancer Network and Society of Nuclear Medicine Join to Advance Oncology Imaging Research

Jai Pausch Provides Insight for Managing Emotions When a Spouse is Diagnosed with Cancer in First Column on NCCN.com

Russell W. Budd Named to NCCN Foundation Board

Jai Pausch Addresses Caregiver Concerns in New NCCN Column

Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN

National Business Group on Health Launches Major Initiative to Address Cancer in the Workplace

NCCN Global Leadership Exchange Program Hosts Oncology Experts From China

Coordinating Office Established to Advance MENA/NCCN Collaboration

New Multiple Myeloma Treatment Guidelines for Patients Available from NCCN

New NCCN Program Recognizes Organizations Supporting Coverage for Clinical Trials and Appropriate Off-Label Drug Usage

NCCN Receives $2.1 Million in Oncology Research Funding from Pfizer

NCCN Guidelines for Breast Cancer Updated; Bevacizumab Recommendation Affirmed

Improving Safety for Patients with Cancer; NCCN Safety Summit Features Peter Pronovost, MD, PhD

NCCN Announces New Treatment Guidelines for Patients

Compendia Usage and Off-Label Indications Focus of NCCN Oncology Summit

NCCN Receives $4 Million in Oncology Research Funding from GlaxoSmithKline

National Comprehensive Cancer Network (NCCN) and Proventys Collaborate to Enhance Quality and Efficiency in Cancer Care

NCCN Launches Free NCCN Guidelines Mobile App for iPhone and Android

NCCN Survey Analyzes Clinical Trial Accrual at Academic Cancer Centers

Thomas A. D’Amico, MD Elected Chairman of NCCN Board of Directors

Dr. Mohler Presents Expert Testimony on Prostate Cancer at Federal Hearing

China Continues to Consult NCCN for Guidance on Cancer Treatment

Active Surveillance is an Option for Many Men with Prostate Cancer

NCCN Guidelines™ Expand Their Reach to Japan

Minimal Improvement in Adolescent and Young Adult (AYA) Cancer Patients’ Survival Rate

New NCCN Guidelines™ for Malignant Pleural Mesothelioma Presented at Annual Conference

Experts Highlight Impact of Evidence-Based Practice Guidelines on Cancer Care and Cost

Cancer Care at the End of Life: When is Enough, Enough?

Risk Stratification Imperative to Treatment Selection in Patients with AML

HPV-Related Cancer Not Confined to Cervix

Therapy Guidance for Patients with Colorectal Cancer Discussed at NCCN® Annual Conference

Sam Donaldson Named Inaugural Chair of NCCN Foundation Board

New Service Offers Timely Access to Updates in NCCN Guidelines™ & NCCN Compendium™

Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer

NCCN Organizing National Summit for Appropriate Use of REMS in Cancer Care

NCCN Guidelines for Prostate Cancer Updated to Stress Careful Consideration of Active Surveillance

NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy

NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options

NCCN Emphasizes Tailored Treatment in Discovery Health Channel Program Metastatic Breast Cancer: Individualizing Treatment

Annual Screening Mammography Continues to be Recommended in Updated NCCN Guidelines for Breast Cancer Screening and Diagnosis

NCCN Receives Research Grant to Evaluate Pralatrexate in Solid Tumors and Hematologic Malignancies

NCCN Posts Comparative Effectiveness White Paper for Public Comment

NCCN Guidelines for Kidney Cancer Updated to Include Pazopanib for Advanced Disease; Free Webinar Discusses Updates

NCCN Updates Colorectal Screening Guidelines to Include Additional Primary Screening Modality

Updated NCCN Guidelines for Breast Cancer Discourages Prophylactic Mastectomy in Women Other Than Those at High Risk

UnitedHealthcare Gives Physicians Free Access to National Comprehensive Cancer Network Compendium

Updated NCCN Guidelines for AML Include Risk Stratification to Assist in Treatment Selection

NCCN Teams with Discovery Health Channel to Focus on Living with Advanced Non-Small Cell Lung Cancer

NCCN Updates NHL Guidelines Following FDA Approval of Pralatrexate

Updated NCCN Guidelines for Cervical Cancer Screening Highlight Appropriate Use of New HPV DNA Tests

National Comprehensive Cancer Network and Clinical Care Options to Collaborate on Unique Education Based on the NCCN Guidelines

NCCN Holds Oncology Research Best Practices Conference

NCCN Stresses Importance of PSA Testing in High-Risk Men

NCCN Updates Infection Guidelines to Include Information about H1N1 Virus (Swine flu)

NCCN Will Convene National Policy Summit on Comparative Effectiveness in Cancer Care

Industry Professionals Get Schooled in Real-World Oncology Issues at NCCN Academy

Tool shows promise for measuring productivity of mid-level oncology providers

NCCN Updates Supportive Care Guidelines for VTE

NCCN Updates Guidelines for Central Nervous System (CNS) Cancers

NCCN Oncology Research Program Celebrates 10th Anniversary by Closing in on $20 Million in Funding; Program Expands into Developmental Therapies

NCCN Updates Kidney Cancer Guidelines to Incorporate FDA Approval of Everolimus

NCCN Presents Updates to NCCN Guidelines for Thyroid Carcinoma

Early Detection Remains Key in Updated NCCN Guidelines for Ovarian Cancer

Experts Weigh In on Controversial Issue of Determining Value of Cancer Care at NCCN Conference

New NCCN Guidelines for Primary Cutaneous B-Cell Lymphoma and Updates to NCCN Guidelines for Non-Hodgkin’s Lymphomas

NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines

Is Smaller Better? Minimally Invasive Oncologic Surgery Options Discussed at NCCN Conference

Cancer advocates, survivors address the “now what?” stage of cancer

NCCN Adds Survivorship Section to Colon and Rectal Cancer Guidelines

JNCCN names new publishing company

NCCN Updates Breast Cancer and Breast Cancer Risk Reduction Guidelines

NCCN Receives $4 Million Oncology Research Grant from Wyeth

NCCN and SEHA Collaborate to Improve Cancer Care

NCCN provides oncology training for nearly 200 medical professionals in Philadelphia

Combination Cancer Therapy is Focus of $1M Merck Research Grant Received by NCCN

NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer

NCCN Updates Guidelines for Colorectal Cancer

NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies

Important Updates to the NCCN Drugs & Biologics Compendium™ Non-Small Cell Lung Cancer

JNCCN Names New Editor-in-Chief

Zynx Health Partners with the National Comprehensive Cancer Network (NCCN) to Launch New Product

NCCN Member Institution Opens Oncology-Specific Clinical Research Center

NCCN Named as Strategic Collaborator of BCBSA

Pietenpol Chosen to Lead Vanderbilt-Ingram Cancer Center

NCCN and UnitedHealthcare Collaboration Benefits Patients

To the marrow: New drugs offer hope in treatment of blood cancer

Genome Update Defines Landscape of Breast and Colon Cancers--Represents next major step in cancer genome sequencing

OSU Study: Personal Digital Assistants Help Cancer Patients

Discovery Could Increase Tumors` Sensitivity to Radiation Therapy

Targeted Marrow Irradiation Reduces Side Effects for Bone Marrow Transplant Patients

Roswell Park Receives Grant to Further Research in Multiple Myeloma

Cancer Patients, Lost in a Maze of Uneven Care

Small, vital gains over cancer

Michael V. Seiden, M.D., Ph.D., Takes Office As Fox Chase Cancer Center President and CEO

Roswell Park CEO Introduced

NCCN Member Institution Receives $8.95 Million Drug Discovery Grant from NCI

Your Breast-Cancer SURVIVAL Guide

PERSONAL HEALTH: Nausea? There's No Need to Suffer in Silence

NCCN Director: 2006 Project Aims to Expedite Data Collection

Fewer women to receive chemo for breast cancer

Tackling the Emotional Side of Cancer

The NCCN guidelines: how do they relate to community oncology practice?

Cancer Care for Elderly Gets Refined to Find The Right Treatment

Utilization of Rituximab Therapy in Patients (pts) with Newly Diagnosed Follicular (FL) and Diffuse Large B Cell (DLCL) Non-Hodgkins Lymphoma (NHL) in the United States: An Analysis from the National Comprehensive Cancer Network (NCCN)

Emergence of Sentinel Node Biopsy in Breast Cancer as Standard-of-Care in Academic Comprehensive Cancer Centers

Medtronic To Support New Research Effort by NCCN Network of Cancer Centers

Prostate cancer: Kinder cuts mean sharper dilemmas

Prostate dilemmas: Early detection is forcing more men to weigh the difficult treatment options

CNN.com Health Guidelines Released for Cancer Pain Treatment

Cancer Patients Get Simple Words to Say How it Hurts

Hartford Life® and Strategic Health Development Corporation® Team Up With The National Comprehensive Cancer Network®

Pharmacia Gives $3.15 Million Grant To NCCN To Advance Innovative Cancer Research Collaboration

JNCCN Honored with APEX Award for Publication Excellence

CMS Officially Recognizes NCCN Drugs & Biologics Compendium™

NCCN Expands Disclosure Policy

NCCN Previews Chemotherapy Order Templates™

NCCN Updates Non-Hodgkin’s Lymphoma Guidelines

Oncology Researcher Forecasts Increased Use of Predictive Medicine at NCCN Conference

Prepare Now for Aging Population’s Breast Cancer Surge, Doctors Urge at NCCN Annual Conference

Sequence of Treatments May Induce Clinical Response in Metastatic Renal Cell Carcinoma Patients

BCBSA and NCCN Announce Strategic Collaboration

Is Cancer Community In Alignment About ‘Cure’ and ‘Costs’? NCCN Conference Panel Asks

NCCN Conference Offers a Peek into Internet Medicine’s Future

NCCN and Cerner Collaborate to Improve Oncology Care

NCCN Updates Ovarian Cancer Guidelines

NCCN Updates Breast Cancer Guidelines

JNCCN Articles Now Available On Medscape

NCCN Updates Cancer- and Treatment-Related Anemia Guidelines

NCCN Updates Pancreatic Adenocarcinoma Guidelines

NCCN Receives Major Grant for Anti-Cancer Drug Study

JNCCN Named as Reference by CMS for Off-Label Coverage Decisions

NCCN Updates Non-Small Cell Lung Cancer Guidelines

NCCN Updates Multiple Myeloma Guidelines

NCCN Updates Central Nervous System Cancers Guidelines

JNCCN Task Force Supplements Now Available On-Line

NCCN Updates Hepatobiliary Cancer Guidelines

NCCN Updates Dermatofibrosarcoma Protuberans Guidelines

NCCN Updates Cervical Cancer Guidelines

NCCN Updates Kidney Cancer Guidelines

NCCN Updates Non-Hodgkin’s Lymphoma Guidelines

NCCN Task Force Develops Clinical Recommendations for PET in Cancer Evaluation and Management

NCCN Updates Thyroid Carcinoma Guidelines

NCCN Updates Head and Neck Cancers Guidelines

NCCN Updates Esophageal and Gastric Cancer Guidelines

NCCN Updates Prevention and Treatment of Cancer-Related Infections Guidelines

Roswell Park CEO Introduced

NCCN Board of Directors Welcomes New Chair and Vice-Chair

NCCN Adds 21st Member

Arresting Stem Cells May Trump Tumor Shrinkage in Rating Cancer Treatments, Researcher Says

Robot Spurs Men’s Recovery After Surgery, Urologist Says at NCCN Annual Conference

Cancer Drugs’ ‘Spectacular Costs’ Shift Market Dynamic, MDs Say at NCCN Annual Conference

Journalists Acknowledge Their Own Battles in War on Cancer at NCCN Annual Conference

NCCN 12th Annual Conference: Clinical Practice Guidelines in Oncology & Quality Cancer Care™ to Be Held March 14 – 18, 2007 in Hollywood, Florida

NCCN Updates Cancer- and Treatment-Related Anemia Guidelines

NCCN Updates Myelodysplastic Syndromes (MDS) Guidelines

NCCN Updates Occult Primary Guidelines

NCCN to Present Guidelines in China

NCCN Updates Breast Cancer Risk Reduction Guidelines

Pharmacia Gives $3.15 Million Grant to NCCN to Advance Innovative Cancer Research Collaboration

NCCN Updates Non-Small Cell Lung Cancer Guidelines

NCCN Updates Colon Cancer Guidelines

NCCN Updates Prostate Cancer Guidelines

NCCN Updates Multiple Myeloma Guidelines

NCCN Offers HER2 Testing for Breast Cancer Patients™

NCCN Updates Antiemesis Guidelines

NCCN Drugs and Biologics Compendium™ New Search Enabled

NCCN Updates Breast Cancer Guidelines

NCCN Breast Cancer Guidelines now available at Medscape

Agenda and Speakers for NCCN 12th Annual Conference Now Available

NCCN Updates Chronic Myelogenous Leukemia Guidelines

NCCN Receives $2 Million Grant from Pfizer

NCCN to Host First Annual Hematologic Malignancies Congress in NYC

Oncology Groups Publish Seven Measures of Quality Care for Breast and Colorectal Cancers

JNCCN Indexed in EMBASE, EMCare and Scopus

JNCCN Readership Scores Continue to Rise

ASCO Requests CMS to Recognize NCCN Compendium

NCCN Announces Important Updates to Soft Tissue Sarcoma Guidelines

NCCN Announces Important Updates to Cancer- and Treatment-Related Anemia Guidelines

NCCN Announces Important Updates to Pancreatic Adenocarcinoma Clinical Practice Guidelines

NCCN Introduces Venous Thromboembolic Disease Guidelines

NCCN Adds 20th Member

NCCN Announces Important Updates to Kidney Cancer Clinical Practice Guidelines

NCCN Announces Important Updates to Ovarian Cancer Clinical Practice Guidelines

NCCN Announces Important Updates to Myelodysplastic Syndromes Guidelines

Top Cancer Experts Gather at NCCN 11th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™

Christopher E. Desch, M.D., Joins National Comprehensive Cancer Network as National Medical Director

NCCN Offers On-Line Tool for 2006 CMS Oncology Demonstration Program

NCCN Announces Important Updates to Several Clinical Practice Guidelines

NCCN Announces Two New Breast Cancer Resources

NCCN 11th Annual Conference: Clinical Practice Guidelines in Oncology & Quality Cancer Care™

Centers for Medicare and Medicaid Services Encourages Use of NCCN Guidelines in Oncology Demonstration Project for 2006

NCCN and Roche Collaborate on Innovative Cancer Research

NCCN Releases Updated Treatment Guidelines for Non-Small Cell Lung Cancer

National Comprehensive Cancer Network and Univision Collaborate to Raise Cancer Awareness Among Hispanics

NCCN Releases Growth Factors and Lung, Kidney, Testicular, Gastric and Esophageal Cancers Chapters of the NCCN Drugs & Biologics Compendium™

NCCN Launches On-Demand Learning at www.nccn.org

National Comprehensive Cancer Network and Multiple Myeloma Research Foundation Launch Multiple Myeloma Resource Line for Physicians

Diane E. Paul, MS, RN, Joins National Comprehensive Cancer Network as Vice President, Clinical Trials Network

NCCN Releases New Myeloid Growth Factors Clinical Practice Guidelines

New Treatment Options Featured in NCCN Non-Small Cell Lung Cancer Clinical Practice Guidelines

NCCN Releases Acute Myeloid Leukemia and Chronic Myelogenous Leukemia Chapters of the NCCN Drugs & Biologics Compendium™

Comprehensive Help is Now Available When Cancer Patients Experience Distress

Patricia J. Goldsmith Joins National Comprehensive Cancer Network as Senior Vice President, Business Development, Public Affairs and Policy

NCCN Releases First Three Chapters of the NCCN Drugs & Biologics Compendium™

National Comprehensive Cancer Network Wins Medical Marketing & Media Award

NCCN Announces the NCCN Drugs and Biologics Compendium™

New Treatment Options Featured in NCCN Colorectal Clinical Practice Guidelines

National Comprehensive Cancer Network Places Patients and Physicians on the Same Page - Latest Treatment Guidelines Demystify How Care Decisions Are Made In Advanced Cancer and Palliative Care

NCCN and ACS Release Revised Breast Cancer Treatment Guidelines for Patients

Cancer Pain Can Be Treated: New Patient Guidelines Help Patients and Physicians Discuss Options

Nausea and Vomiting in Cancer Patients Can be Controlled or Prevented

Dr. William P. Vaughan Named New Chairman of the Board of the National Comprehensive Cancer Network

NCCN Guidelines Provide Oncologists Worldwide with Current and Up-to-Date Information on the Latest Treatment Options for Cancer Patients – Complete Library of Practice Guidelines in Oncology Now Available On-Line at www.nccn.org

NCCN Revises Breast Cancer Treatment Guidelines

The National Comprehensive Cancer Network Recognizes National Cancer Fatigue Awareness Day With The Launch Of Two New Supportive Care Guidelines: Cancer and Treatment-Related Anemia Practice Guidelines for Clinicians and Cancer-Related Fatigue Treatment Guidelines for Patients

The National Comprehensive Cancer Network Launches New Journal To Focus On Oncology Standards Of Care

The National Comprehensive Cancer Network Launches Clinical Trials Network to Speed Drug Discovery

National Comprehensive Cancer Network CEO Named Vice President of Executive Board of Patient Advocate Foundation

The National Comprehensive Cancer Network Announces Release of Treatment Guidelines for Patients

The National Comprehensive Cancer Network Provides Free Information to Help Women with Breast Cancer Make More Informed Treatment Decisions

National Comprehensive Cancer Network Breast Cancer Database: Five Years in Operation and 10,000 Patients Enrolled

The National Comprehensive Cancer Network Announces Release of Lung Cancer Treatment Guidelines for Patients

The National Comprehensive Cancer Network Provides Physicians Easier Identification of Clinical Trials for Their Patients

National Comprehensive Cancer Network Announces 8th Annual Conference

National Comprehensive Cancer Network Announces New Journal

New NCCN Treatment Recommendations for Colon and Rectal Cancers

Researchers Receive $1,886,237 in Funding from NCCN Clinical Trials Network

New Cancer Support Resources Available in Spanish

National Comprehensive Cancer Network and American Cancer Society Announce Release of New Fatigue and Anemia Treatment Guidelines for Patients with Cancer

New Bladder Cancer Treatment Guidelines Available for Patients

National Comprehensive Cancer Network CEO Honored with Humanitarian Award

NCCN Announces Release of New Cancer Testing CD-ROM

New Treatment Options Featured in NCCN Multiple Myeloma Clinical Practice Guidelines

NCCN Announces Release of Newly-Updated Breast Cancer Guidelines for Patients

NCCN Breast Cancer Outcomes Project Plays Significant Role in Research

New Treatment Options Featured in NCCN Breast Cancer Clinical Practice Guidelines

New Non-Hodgkin’s Lymphoma Treatment Guidelines Available for Patients

NCCN Announces Leukemia Resource Line for Physicians

The National Comprehensive Cancer Network Announces Promotions

New Treatment Options Featured in NCCN Non-Small Cell Lung Cancer Clinical Practice Guidelines

NCCN and ACS Bladder Cancer Guide Aids Patients and Families

NCCN Announces Release of Gastrointestinal Stromal Tumors (GIST) Task Force Report

David C. Hohn, MD Elected Chairman of the Board of the National Comprehensive Cancer Network

New Treatment Options Featured in NCCN Antiemesis Guidelines

Updated Cancer Support Resources Available - Learn How to Prevent Nausea and Vomiting –Common Cancer Treatment Side Effects

Stephen B. Edge, MD, FACS Elected to Executive Committee of the National Comprehensive Cancer Network

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital